BioCentury | Nov 19, 2012
Company News

Arrayit diagnostic, supply/service news

...stake, in its Arrayit Diagnostics Inc. subsidiary as a dividend to shareholders on Jan. 15. Arrayit...
...3.34 shares of Arrayit held. Arrayit Diagnostics expects to list on the OTC Bulletin Board. Arrayit's...
...for its OvaDx biomarker-based diagnostic for pre-symptomatic ovarian cancer. OvaDx is available for research purposes. Arrayit...
BioCentury | Oct 8, 2012
Financial News

Arrayit proposes private placement

Arrayit Corp. (OTCBB:ARYC), Sunnyvale, Calif. Business: Microarrays, Diagnostic, Supply/Service Date announced: 10/4/12 Type: Private placement To be raised: Up to $8 million Shares: TBD Price prior: $0.19 Shares outstanding prior: 27.8 million Investor: American Equity...
BioCentury | Apr 23, 2012
Clinical News

OvaDx diagnostic data

...a sensitivity and specificity of 79.7% and 100%, respectively, for identifying patients with ovarian cancer. Arrayit...
...this quarter to support PMA approval. OvaDx is available in the U.S. for research purposes. Arrayit Corp....
BioCentury | Dec 19, 2011
Company News

Arrayit diagnostic, supply/service news

...Arrayit said it would distribute its 19.4 million shares, or 78.18% stake, in its Arrayit Diagnostics...
...dividend to existing shareholders. The dividend distribution date and details will be announced next quarter. Arrayit...
...for its OvaDx biomarker-based diagnostic for pre-symptomatic ovarian cancer. OvaDx is available for research purposes. Arrayit...
BioCentury | Dec 14, 2009
Company News

Arrayit, Wayne State University deal

...Arrayit's Arrayit Diagnostics Inc. subsidiary received an exclusive, worldwide license to develop and commercialize a diagnostic...
...for ovarian cancer. The test will screen for early stage ovarian cancer in pre-symptomatic women. Arrayit...
...and expects the test to be available early to mid-2010. Financial terms were not disclosed. Arrayit Corp....
BioCentury | Oct 13, 2008
Company News

Biosystems International, Integrated Media Holdings Inc. deal

...Integrated Media's Arrayit Co. business received an exclusive, worldwide license to use BioSystems' Plasma Scan antibody...
...microarrays will be developed as diagnostics. The companies will share R&D costs and revenues, and Arrayit...
Items per page:
1 - 6 of 6
BioCentury | Nov 19, 2012
Company News

Arrayit diagnostic, supply/service news

...stake, in its Arrayit Diagnostics Inc. subsidiary as a dividend to shareholders on Jan. 15. Arrayit...
...3.34 shares of Arrayit held. Arrayit Diagnostics expects to list on the OTC Bulletin Board. Arrayit's...
...for its OvaDx biomarker-based diagnostic for pre-symptomatic ovarian cancer. OvaDx is available for research purposes. Arrayit...
BioCentury | Oct 8, 2012
Financial News

Arrayit proposes private placement

Arrayit Corp. (OTCBB:ARYC), Sunnyvale, Calif. Business: Microarrays, Diagnostic, Supply/Service Date announced: 10/4/12 Type: Private placement To be raised: Up to $8 million Shares: TBD Price prior: $0.19 Shares outstanding prior: 27.8 million Investor: American Equity...
BioCentury | Apr 23, 2012
Clinical News

OvaDx diagnostic data

...a sensitivity and specificity of 79.7% and 100%, respectively, for identifying patients with ovarian cancer. Arrayit...
...this quarter to support PMA approval. OvaDx is available in the U.S. for research purposes. Arrayit Corp....
BioCentury | Dec 19, 2011
Company News

Arrayit diagnostic, supply/service news

...Arrayit said it would distribute its 19.4 million shares, or 78.18% stake, in its Arrayit Diagnostics...
...dividend to existing shareholders. The dividend distribution date and details will be announced next quarter. Arrayit...
...for its OvaDx biomarker-based diagnostic for pre-symptomatic ovarian cancer. OvaDx is available for research purposes. Arrayit...
BioCentury | Dec 14, 2009
Company News

Arrayit, Wayne State University deal

...Arrayit's Arrayit Diagnostics Inc. subsidiary received an exclusive, worldwide license to develop and commercialize a diagnostic...
...for ovarian cancer. The test will screen for early stage ovarian cancer in pre-symptomatic women. Arrayit...
...and expects the test to be available early to mid-2010. Financial terms were not disclosed. Arrayit Corp....
BioCentury | Oct 13, 2008
Company News

Biosystems International, Integrated Media Holdings Inc. deal

...Integrated Media's Arrayit Co. business received an exclusive, worldwide license to use BioSystems' Plasma Scan antibody...
...microarrays will be developed as diagnostics. The companies will share R&D costs and revenues, and Arrayit...
Items per page:
1 - 6 of 6